Published in Circ Res on September 30, 2011
Cardiac Stem Cell Infusion in Patients With Ischemic CardiOmyopathy (SCIPIO) (SCIPIO) | NCT00474461
Cell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directions. Circ Res (2013) 3.56
Retracted Cardiomyogenesis in the aging and failing human heart. Circulation (2012) 2.16
Regenerating new heart with stem cells. J Clin Invest (2013) 1.83
Cardiac regenerative capacity and mechanisms. Annu Rev Cell Dev Biol (2012) 1.70
β-Adrenergic regulation of cardiac progenitor cell death versus survival and proliferation. Circ Res (2012) 1.66
Tracking chromatid segregation to identify human cardiac stem cells that regenerate extensively the infarcted myocardium. Circ Res (2012) 1.63
Age-associated defects in EphA2 signaling impair the migration of human cardiac progenitor cells. Circulation (2013) 1.61
Evidence for Mechanisms Underlying the Functional Benefits of a Myocardial Matrix Hydrogel for Post-MI Treatment. J Am Coll Cardiol (2016) 1.42
The advancing field of cell-based therapy: insights and lessons from clinical trials. J Am Heart Assoc (2013) 1.40
Cardiomyogenesis in the developing heart is regulated by c-kit-positive cardiac stem cells. Circ Res (2012) 1.37
Bioenergetic and functional consequences of cellular therapy: activation of endogenous cardiovascular progenitor cells. Circ Res (2012) 1.34
Cell-based therapy for prevention and reversal of myocardial remodeling. Am J Physiol Heart Circ Physiol (2012) 1.31
Functional consequences of human induced pluripotent stem cell therapy: myocardial ATP turnover rate in the in vivo swine heart with postinfarction remodeling. Circulation (2013) 1.29
Vascular endothelial growth factor in heart failure. Nat Rev Cardiol (2013) 1.16
Angiogenesis in the infarcted myocardium. Antioxid Redox Signal (2012) 1.15
Increased potency of cardiac stem cells compared with bone marrow mesenchymal stem cells in cardiac repair. Stem Cells Transl Med (2012) 1.10
Mechanisms of load dependency of myocardial ischemia reperfusion injury. Am J Cardiovasc Dis (2013) 1.06
Patching the heart: cardiac repair from within and outside. Circ Res (2013) 1.04
Activation of growth hormone releasing hormone (GHRH) receptor stimulates cardiac reverse remodeling after myocardial infarction (MI). Proc Natl Acad Sci U S A (2011) 1.04
Fibronectin is essential for reparative cardiac progenitor cell response after myocardial infarction. Circ Res (2013) 1.01
Endocrine protection of ischemic myocardium by FGF21 from the liver and adipose tissue. Sci Rep (2013) 0.99
Cardiac side population cells: moving toward the center stage in cardiac regeneration. Circ Res (2012) 0.98
Direct visualization of cell division using high-resolution imaging of M-phase of the cell cycle. Nat Commun (2012) 0.98
Low-intensity pulsed ultrasound induces angiogenesis and ameliorates left ventricular dysfunction in a porcine model of chronic myocardial ischemia. PLoS One (2014) 0.95
Secondary sphere formation enhances the functionality of cardiac progenitor cells. Mol Ther (2012) 0.94
Cardiac stem cell niches. Stem Cell Res (2014) 0.91
Stem cell therapy for cardiac dysfunction. Springerplus (2014) 0.90
Cardiomyocyte renewal in humans. Circ Res (2012) 0.90
Angiogenesis effect of therapeutic ultrasound on ischemic hind limb in mice. Am J Transl Res (2014) 0.90
Current stem cell delivery methods for myocardial repair. Biomed Res Int (2012) 0.89
Resveratrol treatment reduces cardiac progenitor cell dysfunction and prevents morpho-functional ventricular remodeling in type-1 diabetic rats. PLoS One (2012) 0.89
Innate regeneration in the aging heart: healing from within. Mayo Clin Proc (2013) 0.89
Origin of cardiomyocytes in the adult heart. Circ Res (2015) 0.89
The influence of a spatiotemporal 3D environment on endothelial cell differentiation of human induced pluripotent stem cells. Biomaterials (2014) 0.88
Biochemical markers of aging for longitudinal studies in humans. Epidemiol Rev (2013) 0.87
MicroRNAs and Cardiac Regeneration. Circ Res (2015) 0.86
Telomerase expression confers cardioprotection in the adult mouse heart after acute myocardial infarction. Nat Commun (2014) 0.85
Aging Kit mutant mice develop cardiomyopathy. PLoS One (2012) 0.85
Reprogramming and transdifferentiation for cardiovascular development and regenerative medicine: where do we stand? EMBO Mol Med (2015) 0.85
Downregulation of miR-133 via MAPK/ERK signaling pathway involved in nicotine-induced cardiomyocyte apoptosis. Naunyn Schmiedebergs Arch Pharmacol (2013) 0.84
Stem cell stimulation of endogenous myocyte regeneration. Clin Sci (Lond) (2013) 0.83
Mechanisms of myocardial regeneration. Trends Cardiovasc Med (2011) 0.83
Recruitment and retention of human autologous CD34+ CD117+ CD133+ bone marrow stem cells to infarcted myocardium followed by directed vasculogenesis: Novel strategy for cardiac regeneration. Mol Cell Ther (2013) 0.83
At a crossroad: cell therapy for cardiac repair. Circ Res (2013) 0.83
The existence of myocardial repair: mechanistic insights and enhancements. Cardiol Rev (2013) 0.82
Response to Bergmann et al: Carbon 14 Birth Dating of Human Cardiomyocytes. Circ Res (2012) 0.82
Myocardial Isl(+)land: a place with lots of rhythm, but no beat. Circ Res (2012) 0.81
Myocardial regeneration of the failing heart. Heart Fail Rev (2013) 0.81
Transcriptional profiling of HMGB1-induced myocardial repair identifies a key role for Notch signaling. Mol Ther (2013) 0.81
Role of nitric oxide in the maintenance of pluripotency and regulation of the hypoxia response in stem cells. World J Stem Cells (2015) 0.81
Sustained-release delivery of prostacyclin analogue enhances bone marrow-cell recruitment and yields functional benefits for acute myocardial infarction in mice. PLoS One (2013) 0.81
Cardiac stem cells: A promising treatment option for heart failure. Exp Ther Med (2012) 0.81
The potential of stem cells in the treatment of cardiovascular diseases. Stem Cell Rev (2013) 0.80
Recent concepts for the roles of progenitor/stem cell niche in heart repair. Am J Cardiovasc Dis (2011) 0.80
ATP-binding cassette G-subfamily transporter 2 regulates cell cycle progression and asymmetric division in mouse cardiac side population progenitor cells. Circ Res (2012) 0.80
Cardiac stem cells: biology and clinical applications. Antioxid Redox Signal (2014) 0.80
Concurrent Isolation of Three Distinct Cardiac Stem Cell Populations from a Single Human Heart Biopsy. Circ Res (2017) 0.80
Pim1 Kinase Overexpression Enhances ckit(+) Cardiac Stem Cell Cardiac Repair Following Myocardial Infarction in Swine. J Am Coll Cardiol (2016) 0.79
REVIVE Trial: Retrograde Delivery of Autologous Bone Marrow in Patients With Heart Failure. Stem Cells Transl Med (2015) 0.79
Local activation of cardiac stem cells for post-myocardial infarction cardiac repair. J Cell Mol Med (2012) 0.79
Bone marrow therapy for myocardial infarction. JAMA (2011) 0.79
Intracoronary Infusion of Autologous CD133(+) Cells in Myocardial Infarction and Tracing by Tc99m MIBI Scintigraphy of the Heart Areas Involved in Cell Homing. Stem Cells Int (2013) 0.78
Chronic heart failure: opportunities for a bridge between China and the United States. Circ Res (2013) 0.78
CENP-A is essential for cardiac progenitor cell proliferation. Cell Cycle (2013) 0.78
Cardiac aging - Getting to the stem of the problem. J Mol Cell Cardiol (2015) 0.78
Myocyte renewal and therapeutic myocardial regeneration using various progenitor cells. Heart Fail Rev (2014) 0.77
Nuclear Calcium/Calmodulin-dependent Protein Kinase II Signaling Enhances Cardiac Progenitor Cell Survival and Cardiac Lineage Commitment. J Biol Chem (2015) 0.77
Exosome and its roles in cardiovascular diseases. Heart Fail Rev (2015) 0.77
Role of Telomerase in the Cardiovascular System. Genes (Basel) (2016) 0.76
Cardiac regeneration in children. Pediatr Cardiol (2015) 0.76
A Novel Class of Human Cardiac Stem Cells. Cardiol Rev (2015) 0.75
Fetal myocardium in the kidney capsule: an in vivo model of repopulation of myocytes by bone marrow cells. PLoS One (2012) 0.75
Macrophage migration inhibitory factor promotes cardiac stem cell proliferation and endothelial differentiation through the activation of the PI3K/Akt/mTOR and AMPK pathways. Int J Mol Med (2016) 0.75
Accumulation of Mitochondrial DNA Mutations Disrupts Cardiac Progenitor Cell Function and Reduces Survival. J Biol Chem (2015) 0.75
Calcific Aortic Valve Disease: Part 2-Morphomechanical Abnormalities, Gene Reexpression, and Gender Effects on Ventricular Hypertrophy and Its Reversibility. J Cardiovasc Transl Res (2016) 0.75
Bmi1 and BRG1 drive myocardial repair by regulating cardiac stem cell function in acute rheumatic heart disease. Exp Ther Med (2017) 0.75
Cardiac cell proliferation is not necessary for exercise-induced cardiac growth but required for its protection against ischaemia/reperfusion injury. J Cell Mol Med (2017) 0.75
Bone marrow cells regenerate infarcted myocardium. Nature (2001) 21.24
Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell (2003) 18.09
Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med (1996) 17.51
Evidence for cardiomyocyte renewal in humans. Science (2009) 14.17
Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat Rev Mol Cell Biol (2006) 10.71
Evidence that human cardiac myocytes divide after myocardial infarction. N Engl J Med (2001) 10.03
Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation (1990) 9.74
Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell (2002) 9.36
Chimerism of the transplanted heart. N Engl J Med (2002) 8.69
Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation (2007) 8.62
Evidence from a genetic fate-mapping study that stem cells refresh adult mammalian cardiomyocytes after injury. Nat Med (2007) 8.06
Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc Natl Acad Sci U S A (2003) 7.87
Human cardiac stem cells. Proc Natl Acad Sci U S A (2007) 7.76
Multipotent embryonic isl1+ progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification. Cell (2006) 7.21
Epicardial progenitors contribute to the cardiomyocyte lineage in the developing heart. Nature (2008) 7.03
Neuregulin1/ErbB4 signaling induces cardiomyocyte proliferation and repair of heart injury. Cell (2009) 6.77
Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch Intern Med (2007) 6.68
Apoptosis in the failing human heart. N Engl J Med (1997) 6.35
Cardiac plasticity. N Engl J Med (2008) 6.29
Multipotent flk-1+ cardiovascular progenitor cells give rise to the cardiomyocyte, endothelial, and vascular smooth muscle lineages. Dev Cell (2006) 6.19
Apoptosis in myocytes in end-stage heart failure. N Engl J Med (1996) 6.19
A myocardial lineage derives from Tbx18 epicardial cells. Nature (2008) 6.15
A sensitive cardiac troponin T assay in stable coronary artery disease. N Engl J Med (2009) 5.81
Evidence for human lung stem cells. N Engl J Med (2011) 5.67
In vivo fate analysis reveals the multipotent and self-renewal capacities of Sox2+ neural stem cells in the adult hippocampus. Cell Stem Cell (2007) 5.32
Immunosurveillance by hematopoietic progenitor cells trafficking through blood, lymph, and peripheral tissues. Cell (2007) 5.17
Human ISL1 heart progenitors generate diverse multipotent cardiovascular cell lineages. Nature (2009) 4.68
Stem cell niches in the adult mouse heart. Proc Natl Acad Sci U S A (2006) 4.58
Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function. Proc Natl Acad Sci U S A (2005) 4.13
Periostin induces proliferation of differentiated cardiomyocytes and promotes cardiac repair. Nat Med (2007) 3.98
Cardiac stem cells possess growth factor-receptor systems that after activation regenerate the infarcted myocardium, improving ventricular function and long-term survival. Circ Res (2005) 3.93
Myocardial regeneration by activation of multipotent cardiac stem cells in ischemic heart failure. Proc Natl Acad Sci U S A (2005) 3.93
Heart failure from the point of view of quantitative anatomy. Am J Cardiol (1960) 3.89
p38 MAP kinase inhibition enables proliferation of adult mammalian cardiomyocytes. Genes Dev (2005) 3.88
Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction. J Clin Invest (2005) 3.61
Bone marrow-derived cell therapy stimulates endogenous cardiomyocyte progenitors and promotes cardiac repair. Cell Stem Cell (2011) 3.49
Intracoronary administration of cardiac progenitor cells alleviates left ventricular dysfunction in rats with a 30-day-old infarction. Circulation (2010) 3.42
Adult cardiac Sca-1-positive cells differentiate into beating cardiomyocytes. J Biol Chem (2003) 3.41
Controversies in ventricular remodelling. Lancet (2006) 3.39
Cardiac stem cells and mechanisms of myocardial regeneration. Physiol Rev (2005) 3.30
Control of cardiac growth by histone acetylation/deacetylation. Circ Res (2006) 3.25
Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. JAMA (2002) 3.24
Local activation or implantation of cardiac progenitor cells rescues scarred infarcted myocardium improving cardiac function. Circ Res (2008) 3.07
Bone marrow cells adopt the cardiomyogenic fate in vivo. Proc Natl Acad Sci U S A (2007) 3.06
Intense myocyte formation from cardiac stem cells in human cardiac hypertrophy. Proc Natl Acad Sci U S A (2003) 2.95
Cardiac regeneration: repopulating the heart. Annu Rev Physiol (2006) 2.92
Targeted expression of cyclin D2 results in cardiomyocyte DNA synthesis and infarct regression in transgenic mice. Circ Res (2004) 2.92
Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia. Circulation (2003) 2.82
Myocyte renewal and ventricular remodelling. Nature (2002) 2.80
Cardiomyogenesis in the adult human heart. Circ Res (2010) 2.79
Myocyte turnover in the aging human heart. Circ Res (2010) 2.77
Lives of a heart cell: tracing the origins of cardiac progenitors. Cell Stem Cell (2008) 2.68
Mef2c is a direct transcriptional target of ISL1 and GATA factors in the anterior heart field during mouse embryonic development. Development (2004) 2.68
Clonality of mouse and human cardiomyogenesis in vivo. Proc Natl Acad Sci U S A (2009) 2.60
Imaging survival and function of transplanted cardiac resident stem cells. J Am Coll Cardiol (2009) 2.58
Origins and fates of cardiovascular progenitor cells. Cell (2008) 2.55
Cardiomyogenic potential of C-kit(+)-expressing cells derived from neonatal and adult mouse hearts. Circulation (2010) 2.52
Wt1 is required for cardiovascular progenitor cell formation through transcriptional control of Snail and E-cadherin. Nat Genet (2009) 2.52
CD34-positive cells exhibit increased potency and safety for therapeutic neovascularization after myocardial infarction compared with total mononuclear cells. Circulation (2006) 2.51
Aging and disease as modifiers of efficacy of cell therapy. Circ Res (2008) 2.51
Gender differences and aging: effects on the human heart. J Am Coll Cardiol (1995) 2.49
The orderly allocation of mesodermal cells to the extraembryonic structures and the anteroposterior axis during gastrulation of the mouse embryo. Development (1999) 2.45
Influence of chronic captopril therapy on the infarcted left ventricle of the rat. Circ Res (1985) 2.23
The post-natal heart contains a myocardial stem cell population. FEBS Lett (2002) 2.23
Identification of a coronary vascular progenitor cell in the human heart. Proc Natl Acad Sci U S A (2009) 2.23
Intramyocardial injection of autologous cardiospheres or cardiosphere-derived cells preserves function and minimizes adverse ventricular remodeling in pigs with heart failure post-myocardial infarction. J Am Coll Cardiol (2011) 2.15
Identification of myocardial and vascular precursor cells in human and mouse epicardium. Circ Res (2007) 2.08
Formation of large coronary arteries by cardiac progenitor cells. Proc Natl Acad Sci U S A (2008) 2.05
Cardiac side population cells have a potential to migrate and differentiate into cardiomyocytes in vitro and in vivo. J Cell Biol (2007) 2.02
Functionally competent cardiac stem cells can be isolated from endomyocardial biopsies of patients with advanced cardiomyopathies. Circ Res (2011) 1.98
The fuzzy logic of physiological cardiac hypertrophy. Hypertension (2007) 1.94
Cardiac neural crest cells contribute to the dormant multipotent stem cell in the mammalian heart. J Cell Biol (2005) 1.93
Regeneration next: toward heart stem cell therapeutics. Cell Stem Cell (2009) 1.92
Molecular basis of cardiac performance. Plasticity of the myocardium generated through protein isoform switches. J Clin Invest (1989) 1.85
Cardiovascular control mechanisms in the conscious state. N Engl J Med (1975) 1.82
Stem cells: lost in translation. Nature (2004) 1.79
Transplantation of cardiac progenitor cells ameliorates cardiac dysfunction after myocardial infarction in mice. J Clin Invest (2009) 1.69
Purification and characterization of heterogeneous pluripotent hematopoietic stem cell populations expressing high levels of c-kit receptor. Blood (1993) 1.62
Adenoviral delivery of E2F-1 directs cell cycle reentry and p53-independent apoptosis in postmitotic adult myocardium in vivo. J Clin Invest (1997) 1.62
Lentivector-mediated clonal tracking reveals intrinsic heterogeneity in the human hematopoietic stem cell compartment and culture-induced stem cell impairment. Blood (2003) 1.60
Pregenerative medicine: developmental paradigms in the biology of cardiovascular regeneration. J Clin Invest (2010) 1.57
Myocardial infarction induces embryonic reprogramming of epicardial c-kit(+) cells: role of the pericardial fluid. J Mol Cell Cardiol (2009) 1.57
Mechanisms of contraction of the normal and failing heart. N Engl J Med (1967) 1.57
Does contractile Ca2+ control calcineurin-NFAT signaling and pathological hypertrophy in cardiac myocytes? Sci Signal (2008) 1.43
Gastrointestinal involvement in leukocytoclastic vasculitis and polyarteritis nodosa. J Rheumatol (1981) 1.42
Cardiomyocyte renewal. N Engl J Med (2009) 1.33
Role of the ATP-binding cassette transporter Abcg2 in the phenotype and function of cardiac side population cells. Circ Res (2008) 1.31
Human hepatic infarction: histopathological and postmortem angiological studies. Liver (1993) 1.23
CD117-positive cells in adult human heart are localized in the subepicardium, and their activation is associated with laminin-1 and alpha6 integrin expression. Stem Cells (2008) 1.20
Molecular imaging of cell death. Methods (2009) 1.17
Myocyte cellular hyperplasia and myocyte cellular hypertrophy contribute to chronic ventricular remodeling in coronary artery narrowing-induced cardiomyopathy in rats. Circ Res (1994) 1.17
BMP signals promote proepicardial protrusion necessary for recruitment of coronary vessel and epicardial progenitors to the heart. Dev Cell (2010) 1.15
Acute renal infarction. J R Soc Med (2005) 1.12
Polyangitis overlap syndrome: a fatal case combined with adult Henoch-Schönlein purpura and polyarteritis nodosa. Pathol Int (2003) 1.10
Left ventricular hypertrophy: a cytometric study on 42 human hearts. J Mol Cell Cardiol (1977) 1.10
Bone marrow embolism in sickle cell disease: a review. Am J Hematol (2005) 1.09
Effects of intracoronary autologous bone marrow cells on left ventricular function in acute myocardial infarction: a systematic review and meta-analysis for randomized controlled trials. Coron Artery Dis (2008) 1.08
Human cardiac stem cells: the heart of a truth. Circulation (2009) 1.02
Hyperplasia of myocyte nuclei in long-term cardiac hypertrophy in rats. J Clin Invest (1987) 0.98
Mechanisms of contraction of the normal and failing heart. N Engl J Med (1967) 0.97
Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell (2003) 18.09
Concern Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet (2011) 11.45
Chimerism of the transplanted heart. N Engl J Med (2002) 8.69
Human cardiac stem cells. Proc Natl Acad Sci U S A (2007) 7.76
Evidence for human lung stem cells. N Engl J Med (2011) 5.67
Stem cell niches in the adult mouse heart. Proc Natl Acad Sci U S A (2006) 4.58
Cardiac stem cell and myocyte aging, heart failure, and insulin-like growth factor-1 overexpression. Circ Res (2004) 4.13
Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function. Proc Natl Acad Sci U S A (2005) 4.13
Cardiac stem cells possess growth factor-receptor systems that after activation regenerate the infarcted myocardium, improving ventricular function and long-term survival. Circ Res (2005) 3.93
Myocardial regeneration by activation of multipotent cardiac stem cells in ischemic heart failure. Proc Natl Acad Sci U S A (2005) 3.93
Cardiac stem cells delivered intravascularly traverse the vessel barrier, regenerate infarcted myocardium, and improve cardiac function. Proc Natl Acad Sci U S A (2005) 3.64
Intracoronary administration of cardiac progenitor cells alleviates left ventricular dysfunction in rats with a 30-day-old infarction. Circulation (2010) 3.42
Bone marrow cells differentiate in cardiac cell lineages after infarction independently of cell fusion. Circ Res (2004) 3.39
Cardiac stem cells and mechanisms of myocardial regeneration. Physiol Rev (2005) 3.30
Local activation or implantation of cardiac progenitor cells rescues scarred infarcted myocardium improving cardiac function. Circ Res (2008) 3.07
Bone marrow cells adopt the cardiomyogenic fate in vivo. Proc Natl Acad Sci U S A (2007) 3.06
Intense myocyte formation from cardiac stem cells in human cardiac hypertrophy. Proc Natl Acad Sci U S A (2003) 2.95
Nuclear targeting of Akt enhances kinase activity and survival of cardiomyocytes. Circ Res (2004) 2.91
Administration of cardiac stem cells in patients with ischemic cardiomyopathy: the SCIPIO trial: surgical aspects and interim analysis of myocardial function and viability by magnetic resonance. Circulation (2012) 2.83
Cardiomyogenesis in the adult human heart. Circ Res (2010) 2.79
Myocyte turnover in the aging human heart. Circ Res (2010) 2.77
Local myocardial insulin-like growth factor 1 (IGF-1) delivery with biotinylated peptide nanofibers improves cell therapy for myocardial infarction. Proc Natl Acad Sci U S A (2006) 2.75
Diabetes promotes cardiac stem cell aging and heart failure, which are prevented by deletion of the p66shc gene. Circ Res (2006) 2.71
Clonality of mouse and human cardiomyogenesis in vivo. Proc Natl Acad Sci U S A (2009) 2.60
Life and death of cardiac stem cells: a paradigm shift in cardiac biology. Circulation (2006) 2.56
Senescence and death of primitive cells and myocytes lead to premature cardiac aging and heart failure. Circ Res (2003) 2.45
Pim-1 regulates cardiomyocyte survival downstream of Akt. Nat Med (2007) 2.39
Human cardiac stem cell differentiation is regulated by a mircrine mechanism. Circulation (2011) 2.38
Adolescent feline heart contains a population of small, proliferative ventricular myocytes with immature physiological properties. Circ Res (2007) 2.38
PI3K rescues the detrimental effects of chronic Akt activation in the heart during ischemia/reperfusion injury. J Clin Invest (2005) 2.36
Akt promotes increased cardiomyocyte cycling and expansion of the cardiac progenitor cell population. Circ Res (2006) 2.34
Exogenous high-mobility group box 1 protein induces myocardial regeneration after infarction via enhanced cardiac C-kit+ cell proliferation and differentiation. Circ Res (2005) 2.32
Activation of cardiac progenitor cells reverses the failing heart senescent phenotype and prolongs lifespan. Circ Res (2008) 2.31
Cardiac progenitor cells and biotinylated insulin-like growth factor-1 nanofibers improve endogenous and exogenous myocardial regeneration after infarction. Circulation (2009) 2.30
Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling. Proc Natl Acad Sci U S A (2003) 2.28
Myocyte death, growth, and regeneration in cardiac hypertrophy and failure. Circ Res (2003) 2.26
Identification of a coronary vascular progenitor cell in the human heart. Proc Natl Acad Sci U S A (2009) 2.23
Notch1 regulates the fate of cardiac progenitor cells. Proc Natl Acad Sci U S A (2008) 2.22
Growth properties of cardiac stem cells are a novel biomarker of patients' outcome after coronary bypass surgery. Circulation (2013) 2.19
Retracted Cardiomyogenesis in the aging and failing human heart. Circulation (2012) 2.16
Cardiac-specific IGF-1 expression attenuates dilated cardiomyopathy in tropomodulin-overexpressing transgenic mice. Circ Res (2002) 2.11
Formation of large coronary arteries by cardiac progenitor cells. Proc Natl Acad Sci U S A (2008) 2.05
Functionally competent cardiac stem cells can be isolated from endomyocardial biopsies of patients with advanced cardiomyopathies. Circ Res (2011) 1.98
Postinfarct cytokine therapy regenerates cardiac tissue and improves left ventricular function. Circ Res (2006) 1.98
Myocardial induction of nucleostemin in response to postnatal growth and pathological challenge. Circ Res (2008) 1.97
Regenerating new heart with stem cells. J Clin Invest (2013) 1.83
Insulin-like growth factor-1 receptor identifies a pool of human cardiac stem cells with superior therapeutic potential for myocardial regeneration. Circ Res (2011) 1.77
Inositol 1, 4, 5-trisphosphate receptors and human left ventricular myocytes. Circulation (2013) 1.73
The young mouse heart is composed of myocytes heterogeneous in age and function. Circ Res (2007) 1.69
Cardiac regeneration. J Am Coll Cardiol (2006) 1.67
Insulin-like growth factor 1 alleviates high-fat diet-induced myocardial contractile dysfunction: role of insulin signaling and mitochondrial function. Hypertension (2012) 1.66
Bone marrow stem cells regenerate infarcted myocardium. Pediatr Transplant (2003) 1.66
Ablation of telomerase and telomere loss leads to cardiac dilatation and heart failure associated with p53 upregulation. EMBO J (2003) 1.66
Genetic deletion of p66(Shc) adaptor protein prevents hyperglycemia-induced endothelial dysfunction and oxidative stress. Proc Natl Acad Sci U S A (2007) 1.63
Tracking chromatid segregation to identify human cardiac stem cells that regenerate extensively the infarcted myocardium. Circ Res (2012) 1.63
Nuclear targeting of Akt enhances ventricular function and myocyte contractility. Circ Res (2005) 1.62
Anthracycline cardiomyopathy is mediated by depletion of the cardiac stem cell pool and is rescued by restoration of progenitor cell function. Circulation (2009) 1.62
Age-associated defects in EphA2 signaling impair the migration of human cardiac progenitor cells. Circulation (2013) 1.61